Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

21.3%

317 terminated/withdrawn out of 1490 trials

Success Rate

73.0%

-13.5% vs industry average

Late-Stage Pipeline

10%

143 trials in Phase 3/4

Results Transparency

55%

474 of 859 completed trials have results

Key Signals

181 recruiting474 with results174 terminated143 withdrawn

Enrollment Performance

Analytics

N/A

730(61.2%)

Phase 2

205(17.2%)

Phase 4

108(9.1%)

Phase 1

78(6.5%)

Early Phase 1

36(3.0%)

Phase 3

35(2.9%)

1192Total

N/A(730)

Phase 2(205)

Phase 4(108)

Phase 1(78)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1490)

Showing 20 of 1490 trials

NCT03876314Not ApplicableCompleted

Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype

Role: collaborator

NCT05987592Not ApplicableRecruiting

BE WELL With Migraine: Brain Education and WELLness With Migraine

Role: lead

NCT05625360Phase 3Active Not Recruiting

REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

Role: lead

NCT07621094Not ApplicableNot Yet Recruiting

Intraosseous Antibiotics for Osseointegration

Role: lead

NCT06340503Not ApplicableCompleted

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

Role: lead

NCT06822049Phase 2Active Not Recruiting

Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)

Role: collaborator

NCT07143838Not ApplicableRecruiting

Enhancing Slow Wave Sleep in Depression

Role: lead

NCT07639593Not ApplicableNot Yet Recruiting

Trial of CGM Technology in Persons Living With Prediabetes

Role: lead

NCT05093959Phase 2Completed

Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction

Role: lead

NCT04077047Not ApplicableCompleted

Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention

Role: lead

NCT07638462Not ApplicableNot Yet Recruiting

RIsE Stroke Mobility Study

Role: lead

NCT05764733Phase 4Recruiting

Bone, Exercise, Alendronate, and Caloric Restriction

Role: lead

NCT05914311Not ApplicableCompleted

Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration

Role: lead

NCT03696797Not ApplicableCompleted

Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

Role: lead

NCT07632157Phase 3Not Yet Recruiting

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

Role: lead

NCT07136415Phase 4Recruiting

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Role: collaborator

NCT06744231Not ApplicableEnrolling By Invitation

Thriving Hearts: Healing-Centered, Integrated, Community Maternity Care

Role: collaborator

NCT07614022Phase 1Not Yet Recruiting

A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)

Role: lead

NCT06746753Phase 4Not Yet Recruiting

Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

Role: lead

NCT04262206Phase 4Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Role: collaborator